Next Article in Journal
Macrocyclic Diterpenoids from Euphorbiaceae as A Source of Potent and Selective Inhibitors of Chikungunya Virus Replication
Next Article in Special Issue
The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues
Previous Article in Journal
Modeling of Solid–Liquid Equilibria in Deep Eutectic Solvents: A Parameter Study
Previous Article in Special Issue
Tissue Distribution and Anti-Lung Cancer Effect of 10-Hydroxycamptothecin Combined with Platycodonis Radix and Glycyrrhizae Radix ET Rhizoma
Open AccessArticle

An Isoxazole Derivative SHU00238 Suppresses Colorectal Cancer Growth through miRNAs Regulation

1,2,†, 2,†, 1, 1, 2, 1,3,* and 2,*
Department of Chemistry, Qianweichang College, Shanghai University, Shanghai 200444, China
School of Life Science, Shanghai University, Shanghai 200444, China
Innovative Drug Research Center, Shanghai University, Shanghai 200444, China
Authors to whom correspondence should be addressed.
These two authors contributed equally to this work.
Academic Editor: Yasuyoshi Miyata
Molecules 2019, 24(12), 2335;
Received: 12 June 2019 / Revised: 22 June 2019 / Accepted: 25 June 2019 / Published: 25 June 2019
(This article belongs to the Special Issue Anti-Cancer Drug: Discovery, Development and Combination)
PDF [2020 KB, uploaded 25 June 2019]


Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. Isoxazoline and isoxazole derivatives represent an important class of five-membered heterocycles, which play a pivotal role in drug discovery. In our previous study, we developed a series of isoxazole derivatives with an efficient method. In this study, we evaluated their effects on tumor cell growth. HCT116 cells were treated with isoxazole derivatives; an cholecystokinin octapeptide (CCK-8) assay was used to calculate the IC50 (half maximal inhibitory concentration) of each derivative. Compound SHU00238, which was obtained by the copper nitrate-mediated [2+2+1] cycloaddition reaction of olefinic azlactone with naphthalene-1,4-dione, has a lower IC50; we analyzed its inhibitory activity in further assays. Cell apoptosis was estimated by flow cytometry analysis in vitro. SHU00238 injection was used to treat tumor-bearing mice. We found that SHU00238 suppressed cell viability and promoted cell apoptosis in vitro. SHU00238 treatment significantly inhibited colonic tumor growth in vivo. Furthermore, we compared the miRNAs expression changes in HCT116 cells before and after SHU00238 treatment. MiRNA profiling revealed that SHU00238 treatment affected cell fate by regulating a set of miRNAs. In conclusion, SHU00238 impedes CRC tumor cell proliferation and promotes cell apoptosis by miRNAs regulation. View Full-Text
Keywords: colorectal cancer; isoxazole derivative; miRNAs; SHU00238; drug discovery colorectal cancer; isoxazole derivative; miRNAs; SHU00238; drug discovery

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Wang, H.; Ma, Y.; Lin, Y.; Liu, J.; Chen, R.; Xu, B.; Liang, Y. An Isoxazole Derivative SHU00238 Suppresses Colorectal Cancer Growth through miRNAs Regulation. Molecules 2019, 24, 2335.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top